Makoto Hara
Direktor/Vorstandsmitglied bei ANGES, INC.
Ursprung des Netzwerks ersten Grades von Makoto Hara
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Generic | 9 | |
| Public Company | Pharmaceuticals: Major | 9 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Makoto Hara
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| RESONA HOLDINGS, INC. | Regional Banks | Director/Board Member | |
| KOBE STEEL, LTD. | Steel | Chief Executive Officer | |
Resona Bank Ltd.
 Resona Bank Ltd. Regional BanksFinance Resona Bank, Ltd. provides commercial banking services. It operates through the following segments: Personal, Corporate, and Market. The Personal segment handles financial services for individual customers including personal loans, asset management, and inherited asset consulting. The Corporate segment focuses on lending, asset management that uses trusts, real estate operations, enterprise pensions, and business growth support. The Market segment engages in funds, foreign and local exchanges, bonds, and derivatives. It also offers current and savings accounts, mortgages, debit and credit cards, pension and insurance products, online and phone banking, and investment trusts. The company was founded on May 15, 1918 and is headquartered in Osaka, Japan. | Regional Banks | Director/Board Member | |
| GURUNAVI, INC. | Internet Software/Services | Director/Board Member | |
| SUMITOMO ELECTRIC INDUSTRIES, LTD. | Electrical Products | Director/Board Member | |
| LIXIL CORPORATION | Building Products | Director/Board Member | |
| NITTO DENKO CORPORATION | Electronic Equipment/Instruments | Director/Board Member | |
| TOWA PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| MORISHITA JINTAN CO., LTD. | Pharmaceuticals: Other | President | |
| JCR PHARMACEUTICALS CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| TAKARA BIO INC. | Medical Specialties | Director/Board Member | |
Kyoto Pharmaceutical Industries Ltd.
 Kyoto Pharmaceutical Industries Ltd. Pharmaceuticals: MajorHealth Technology Kyoto Pharmaceutical Industries Ltd. engages in pharmaceutical products manufacturing. Its products include pharmaceuticals to regulate high-blood pressure, Ischemic heart disease treatment, digitalis formulation, and constipation remedies. The firm also develops and produces laxatives, anti-flatulence and anti-diarrheal medicines, and decongestants and cold medicines. The company was founded on September 5, 1946 and is headquartered in Kyoto, Japan. | Pharmaceuticals: Major | Director/Board Member | |
| Kyushu University | College/University | Graduate Degree | |
| SOLASIA PHARMA K.K. | Pharmaceuticals: Major | Director/Board Member | |
| AnGes Euro Ltd. | Chief Executive Officer Director/Board Member | ||
| National Police Agency | General Government | Director/Board Member | |
AnGes USA, Inc.
 AnGes USA, Inc. Pharmaceuticals: MajorHealth Technology Part of AnGes, Inc., AnGes USA, Inc. develops and manufactures medicines. The company is based in Gaithersburg, MD. Ei Yamada has been the CEO of the company since 2014. | Pharmaceuticals: Major | Chief Executive Officer | |
| FUNPEP COMPANY LIMITED | Biotechnology | Director/Board Member | |
MyBiotics Pharma Ltd.
 MyBiotics Pharma Ltd. BiotechnologyHealth Technology MyBiotics Pharma Ltd. operates as a micro biome pharmaceutical company that develops live bacteria based drugs. It develops MyCrobe and SuperDonor technologies for growing specific bacterial communities on pre-selected particles for stable and resistant raw material and for multi bacterial products. The company was founded in and is headquartered in Ness Ziona, Israel. | Biotechnology | Director/Board Member | |
Oriciro Genomics, Inc.
 Oriciro Genomics, Inc. BiotechnologyHealth Technology Oriciro Genomics, Inc. develops DNA based assembly and amplification technology solutions. The company was founded in December 2018 and is headquartered in Tokyo, Japan. | Biotechnology | Chief Executive Officer | |
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
| Pancreas Research Foundation of Japan | Chairman | ||
| Point Market KK | Director/Board Member | ||
| KIDSWELL BIO CORPORATION | Biotechnology | Director/Board Member |
Statistik
International
| Japan | 23 |
| Vereinigte Staaten | 3 |
| Vereinigtes Königreich | 2 |
| Israel | 2 |
Sektoral
| Health Technology | 13 |
| Finance | 3 |
| Producer Manufacturing | 3 |
| Electronic Technology | 3 |
| Non-Energy Minerals | 2 |
Operativ
| Director/Board Member | 36 |
| Independent Dir/Board Member | 15 |
| Corporate Officer/Principal | 9 |
| Chief Executive Officer | 5 |
| Chief Tech/Sci/R&D Officer | 5 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Makoto Hara
- Unternehmensverbindungen
